RIBSP employees, namely: R. Abitayev, A. Issabek, A. Melisbek and A. Bopi, as part of a scientific internship, underwent an advanced training at the International Vaccine Center in South Korea. The introductory course on Standard Practice in 2024 (GxP course) was based on international quality standards in the development and production of vaccines and biomedical products, including training in accordance with relevant clinical, industrial and laboratory practices (GCP, GMP, GLP – together with GxP), as well as on the basics of biosafety. As a result of the 3-week course, RIBSP employees showed high performance in the GCP exam with the receipt of certificates “GxP” 2024 “introduction to standard practice”.
The acquired knowledge will enable the introduction of the latest technologies and practical skills in the development and implementation of vaccines in the field of biotechnology and bio-production in accordance with international GxP requirements.
